Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Cladribine tablets added to IFN-β in active relapsing MS
ONWARD Study Group
Neurology
Research output
:
Contribution to journal
›
Article
›
peer-review
45
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cladribine tablets added to IFN-β in active relapsing MS'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Interferon
100%
Cladribine
100%
Placebo
33%
Lymphocytopenia
26%
Adverse Event
20%
Patient
20%
Magnetic Resonance Imaging
13%
Inpatient
13%
Therapeutic Procedure
13%
Lesion
6%
Lymphocyte
6%
Disease Activity
6%
Group Therapy
6%
Laboratory
6%
Cells
6%
Incidence
6%
Relapse
6%
Pharmacology, Toxicology and Pharmaceutical Science
Interferon
100%
Tablet
100%
Cladribine
100%
Lymphocytopenia
26%
Adverse Event
20%
Disease Activity
6%
Incidence
6%
Relapse
6%
INIS
interferon
100%
patients
33%
lymphopenia
26%
nmr imaging
13%
safety
13%
laboratories
6%
diseases
6%
comparative evaluations
6%
lymphocytes
6%